For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #199
Wednesday 2 August 2023, 12:38 AM

[Image: Kenny Eliason on Unsplash]
“Spironolactone may reduce atrial fibrillation incidence”
A systematic review of 10 trials of mineralocorticoid receptor antagonists (MRAs; eg, spironolactone) found a 23% reduction in the risk of atrial fibr
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
pubmed.ncbi.nlm.nih.gov/37269781 (Am J Cardiol 2023;199:85–91).